Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dougados

Showing results (291-300 of 362) with videos related to

Pageof 37
Sort By:
Arthritis and Rheumatism|December 2, 2011
Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: results of a multicenter, randomized studyP Mandl, P V Balint, Y Brault, et al.
Seminars in Arthritis and Rheumatism|July 26, 2015
Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohortHelga Radner, Kazuki Yoshida, Maria Dahl Mjaavatten, et al.
Osteoarthritis and Cartilage|May 5, 2009
Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP)J F Maillefert, M Kloppenburg, L Fernandes, et al.
Osteoarthritis and Cartilage|April 18, 2008
Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT task forceL Gossec, J M Jordan, S A Mazzuca, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexateM Schiff, M Keiserman, C Codding, et al.
Osteoarthritis and Cartilage|February 26, 2008
The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) - an OARSI/OMERACT initiativeA V Perruccio, L Stefan Lohmander, M Canizares, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2014
Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trialJ Sieper, R Landewé, M Rudwaleit, et al.
Osteoarthritis and Cartilage|February 26, 2008
The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiativeA M Davis, A V Perruccio, M Canizares, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritisJ Sieper, D van der Heijde, M Dougados, et al.
Osteoarthritis and Cartilage|December 20, 2011
OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trialsR L Manno, C O Bingham, S Paternotte, et al.
Pageof 37

Showing results (291-300 of 362) with videos related to

Sort By:
Pageof 37
Arthritis and Rheumatism|December 2, 2011
Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: results of a multicenter, randomized studyP Mandl, P V Balint, Y Brault, et al.
Seminars in Arthritis and Rheumatism|July 26, 2015
Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohortHelga Radner, Kazuki Yoshida, Maria Dahl Mjaavatten, et al.
Osteoarthritis and Cartilage|May 5, 2009
Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP)J F Maillefert, M Kloppenburg, L Fernandes, et al.
Osteoarthritis and Cartilage|April 18, 2008
Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT task forceL Gossec, J M Jordan, S A Mazzuca, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexateM Schiff, M Keiserman, C Codding, et al.
Osteoarthritis and Cartilage|February 26, 2008
The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) - an OARSI/OMERACT initiativeA V Perruccio, L Stefan Lohmander, M Canizares, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2014
Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trialJ Sieper, R Landewé, M Rudwaleit, et al.
Osteoarthritis and Cartilage|February 26, 2008
The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiativeA M Davis, A V Perruccio, M Canizares, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritisJ Sieper, D van der Heijde, M Dougados, et al.
Osteoarthritis and Cartilage|December 20, 2011
OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trialsR L Manno, C O Bingham, S Paternotte, et al.
Pageof 37